Organigram Global Inc.(OGI)Earnings, Financials & Key Ratios
OGI•NASDAQ
$1.39
$188M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutOrganigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.Show more
- Revenue$186M+16.4%
- EBITDA-$50M-114.1%
- Net Income-$18M+60.9%
- EPS (Diluted)-0.14+70.8%
- Gross Margin3.67%-87.7%
- EBITDA Margin-27.14%-83.9%
- Operating Margin-34.07%-52.7%
- Net Margin-9.55%+66.4%
- ROE-5.43%+65.5%
- ROIC-17.83%-48.4%
- Debt/Equity0.03+72.2%
OGI Key Insights
Organigram Global Inc. (OGI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 16.5%
- ✓Trading at only 0.7x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 34.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
OGI Price & Volume
Organigram Global Inc. (OGI) stock price & volume — 10-year historical chart
Loading chart...
OGI Growth Metrics
Organigram Global Inc. (OGI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years68.87%
5 Years16.48%
3 Years8.47%
TTM68.52%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM134.48%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM127.28%
Return on Capital
10 Years-14.54%
5 Years-23.29%
3 Years-29.4%
Last Year-16.04%
OGI Recent Earnings
Organigram Global Inc. (OGI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 2/12 qtrs (17%)
Q1 2026Latest
Feb 10, 2026EPS
$0.02
Est $0.01
-100.0%
Revenue
$46M
Est $53M
-13.1%
Q4 2025
Dec 16, 2025EPS
$0.20
Est $0.00
-4058.0%
Revenue
$57M
Est $51M
+13.6%
Q3 2025
Aug 13, 2025EPS
$0.03
Est $0.01
-200.0%
Revenue
$52M
Est $73M
-28.8%
Q2 2025
May 12, 2025EPS
$0.05
Est $0.03
-66.7%
Revenue
$46M
Est $65M
-29.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $0.02vs $0.01-100.0% | $46Mvs $53M-13.1% |
| Q4 2025 | Dec 16, 2025 | $0.20vs $0.00-4058.0% | $57Mvs $51M+13.6% |
| Q3 2025 | Aug 13, 2025 | $0.03vs $0.01-200.0% | $52Mvs $73M-28.8% |
| Q2 2025 | May 12, 2025 | $0.05vs $0.03-66.7% | $46Mvs $65M-29.5% |
Based on last 12 quarters of dataView full earnings history →
OGI Peer Comparison
Organigram Global Inc. (OGI) competitors in Cannabis and cannabinoid product companies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CGC | 123.69M | 1.15 | -0.28 | -9.47% | -110.99% | -43.07% | 0.72 | |
 TLRY | 671.17M | 5.76 | -0.17 | 4.84% | -252.55% | -136.55% | 0.22 | |
 ACB | 200.75M | 3.54 | 168.77 | 27.01% | 11.24% | 7.15% | 0.17 | |
 CRON | 999.77M | 2.62 | 64.4% | -4.89% | -0.86% | 0.00 | ||
 SNDL | 373.25M | 1.44 | -32.61 | 2.82% | -1.17% | -1% | 0.15 | |
 SMG | 3.65B | 62.85 | 25.45 | -3.93% | 2.68% | |||
 IIPR | 1.65B | 57.69 | 14.68 | -13.8% | 45.58% | 6.41% | 0.21 | |
 LWAY | 405.93M | 26.65 | 29.94 | 13.74% | 6.52% | 17.25% | 0.00 |
Compare OGI vs Peers
Organigram Global Inc. (OGI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OGI Income Statement
Organigram Global Inc. (OGI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 5.39M | 12.43M | 80.41M | 86.8M | 79.16M | 145.81M | 149.21M | 159.84M | 186.09M | 279.94M |
| Revenue Growth % | -12.06% | 130.64% | 546.98% | 7.94% | -8.79% | 84.19% | 2.33% | 7.13% | 16.42% | 68.52% |
| Cost of Goods Sold | 8.69M | -39.2M | 31.94M | 143.28M | 107.56M | 114.24M | 114.13M | 112.32M | 179.26M | 209.45M |
| COGS % of Revenue | 161.18% | -315.42% | 39.72% | 165.08% | 135.87% | 78.35% | 76.49% | 70.27% | 96.33% | - |
| Gross Profit | -3.3M▲ 0% | -26.77M▼ 712.1% | 48.47M▲ 281.0% | -56.49M▼ 216.5% | -28.4M▲ 49.7% | 31.57M▲ 211.2% | 35.07M▲ 11.1% | 47.52M▲ 35.5% | 6.83M▼ 85.6% | 80.79M▲ 0% |
| Gross Margin % | -61.18% | -215.42% | 60.28% | -65.08% | -35.87% | 21.65% | 23.51% | 29.73% | 3.67% | 28.86% |
| Gross Profit Growth % | -162.04% | -712.1% | 281.02% | -216.55% | 49.73% | 211.16% | 11.1% | 35.5% | -85.63% | - |
| Operating Expenses | 7.8M | 15.22M | 42.37M | 89.02M | 63.42M | 74.72M | 271.48M | 83.19M | 70.24M | 109.4M |
| OpEx % of Revenue | 144.81% | 122.43% | 52.69% | 102.56% | 80.11% | 51.25% | 181.95% | 52.05% | 37.74% | - |
| Selling, General & Admin | 7.39M | 15.22M | 41.3M | 46.47M | 46.47M | 59.21M | 71.68M | 68.14M | 86.88M | 94.31M |
| SG&A % of Revenue | 137.21% | 122.43% | 51.35% | 53.54% | 58.7% | 40.61% | 48.04% | 42.63% | 46.68% | - |
| Research & Development | 0 | 0 | 409K | 1.27M | 3.45M | 5.96M | 12.19M | 11.2M | 10.95M | 10.66M |
| R&D % of Revenue | - | - | 0.51% | 1.46% | 4.36% | 4.09% | 8.17% | 7.01% | 5.88% | - |
| Other Operating Expenses | 410K | 0 | 664K | -6.37M | -5.53M | 5.14M | 193.95M | 3.85M | -27.59M | 3M |
| Operating Income | -11.1M▲ 0% | 36.42M▲ 428.0% | 5.49M▼ 84.9% | -145.51M▼ 2751.9% | -91.82M▲ 36.9% | -43.15M▲ 53.0% | -242.74M▼ 462.5% | -35.67M▲ 85.3% | -63.41M▼ 77.7% | -28.61M▲ 0% |
| Operating Margin % | -205.99% | 292.99% | 6.82% | -167.65% | -115.99% | -29.59% | -162.69% | -22.32% | -34.07% | -10.22% |
| Operating Income Growth % | -990.93% | 428.04% | -84.93% | -2751.9% | 36.9% | 53% | -462.53% | 85.3% | -77.75% | - |
| EBITDA | -9.54M | 39.94M | 14.39M | -127.55M | -60.79M | -18.24M | -219.31M | -23.59M | -50.5M | -9.05M |
| EBITDA Margin % | -177.12% | 321.38% | 17.89% | -146.96% | -76.79% | -12.51% | -146.99% | -14.76% | -27.14% | -3.23% |
| EBITDA Growth % | -569.83% | 518.48% | -63.98% | -986.45% | 52.34% | 69.99% | -1102.12% | 89.24% | -114.05% | 51.34% |
| D&A (Non-Cash Add-back) | 1.56M | 3.53M | 8.9M | 17.96M | 31.03M | 24.91M | 23.43M | 12.08M | 12.91M | 19.56M |
| EBIT | -10.55M | 37.87M | 3.79M | -140.62M | -127.74M | -13.94M | -48.79M | -35.67M | -27.66M | 11.45M |
| Net Interest Income | -264K | -10.09M | -9.67M | -6.01M | -2.96M | -429K | 3.41M | 0 | 825.7K | 198.96K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 3.69M | 0 | 825.7K | 198.96K |
| Interest Expense | 264K | 10.09M | 9.67M | 6.01M | 2.96M | 429K | 277.85K | 0 | 0 | 0 |
| Other Income/Expense | 288K | -8.64M | -11.36M | -1.12M | -38.88M | 28.78M | -184.21M | -9.77M | 35.74M | 32.99M |
| Pretax Income | -10.81M▲ 0% | 27.78M▲ 356.9% | -5.88M▼ 121.2% | -146.63M▼ 2395.8% | -130.7M▲ 10.9% | -14.37M▲ 89.0% | -233M▼ 1521.3% | -45.44M▲ 80.5% | -27.66M▲ 39.1% | 4.38M▲ 0% |
| Pretax Margin % | -200.65% | 223.49% | -7.31% | -168.94% | -165.11% | -9.86% | -156.16% | -28.43% | -14.87% | 1.56% |
| Income Tax | 0 | 5.65M | 3.63M | -10.47M | 0 | -88K | -3.52M | 0 | -9.89M | -6.25M |
| Effective Tax Rate % | 0% | 20.35% | -61.77% | 7.14% | 0% | 0.61% | 1.51% | 0% | 35.74% | -142.62% |
| Net Income | -10.89M▲ 0% | 20.51M▲ 288.4% | -9.54M▼ 146.5% | -136.16M▼ 1326.9% | -130.7M▲ 4.0% | -14.28M▲ 89.1% | -229.48M▼ 1506.7% | -45.44M▲ 80.2% | -17.78M▲ 60.9% | 18.15M▲ 0% |
| Net Margin % | -202.08% | 165.04% | -11.87% | -156.87% | -165.11% | -9.8% | -153.8% | -28.43% | -9.55% | 6.48% |
| Net Income Growth % | -1386.23% | 288.37% | -146.52% | -1326.92% | 4% | 89.07% | -1506.65% | 80.2% | 60.88% | 134.48% |
| Net Income (Continuing) | -10.81M | 22.12M | -9.5M | -136.16M | -130.7M | -14.28M | -229.48M | -45.44M | -17.78M | 18.15M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.45▲ 0% | 0.65▲ 244.4% | -0.27▼ 141.5% | -3.15▼ 1066.7% | -2.04▲ 35.2% | -0.18▲ 91.2% | -2.82▼ 1466.7% | -0.48▲ 83.0% | -0.14▲ 70.8% | 0.13▲ 0% |
| EPS Growth % | -879.9% | 244.44% | -141.54% | -1066.67% | 35.24% | 91.18% | -1466.67% | 82.98% | 70.83% | 127.28% |
| EPS (Basic) | -0.45 | 0.68 | -0.27 | -3.15 | -2.04 | -0.18 | -2.82 | -0.48 | -0.14 | - |
| Diluted Shares Outstanding | 24.3M | 31.71M | 35.23M | 43.17M | 64.03M | 85.3M | 81.29M | 95.29M | 127.67M | 136.77M |
| Basic Shares Outstanding | 24.3M | 30.14M | 35.23M | 43.17M | 64.03M | 80.01M | 81.29M | 95.29M | 127.67M | 134.93M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
OGI Balance Sheet
Organigram Global Inc. (OGI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 44.67M | 203.21M | 196.28M | 170.2M | 260.62M | 221.62M | 155.98M | 262.22M | 204.56M | 256.34M |
| Cash & Short-Term Investments | 33.96M | 130.06M | 47.94M | 74.73M | 183.84M | 98.91M | 33.86M | 107.57M | 29.03M | 62.91M |
| Cash Only | 1.96M | 55.06M | 47.55M | 24.6M | 55.37M | 68.52M | 33.86M | 106.75M | 28.2M | 62.11M |
| Short-Term Investments | 32M | 75M | 380K | 50.13M | 128.48M | 30.4M | 0 | 821K | 826K | 804.34K |
| Accounts Receivable | 1.01M | 793K | 11.63M | 16.98M | 21M | 46.37M | 27.46M | 37.15M | 64.86M | 49.9M |
| Days Sales Outstanding | 68.2 | 23.29 | 52.8 | 71.39 | 96.81 | 116.08 | 67.17 | 84.84 | 127.21 | 71.43 |
| Inventory | 5.41M | 64.83M | 113.8M | 71.76M | 48.82M | 68.28M | 80.95M | 82.52M | 123.95M | 132.6M |
| Days Inventory Outstanding | 227.16 | -603.56 | 1.3K | 182.8 | 165.66 | 218.16 | 258.89 | 268.18 | 252.38 | 216.44 |
| Other Current Assets | 3.58M | 1.22M | 5.82M | 0 | 0 | 2.21M | 13.7M | 25.86M | -24.95M | 10.92M |
| Total Non-Current Assets | 48.14M | 99.35M | 232.24M | 247.42M | 293.4M | 355.48M | 142.48M | 145.64M | 199.11M | 273.9M |
| Property, Plant & Equipment | 45.35M | 98.64M | 219.05M | 247.42M | 235.94M | 259.82M | 99.05M | 96.23M | 122.98M | 123.38M |
| Fixed Asset Turnover | 0.12x | 0.13x | 0.37x | 0.35x | 0.34x | 0.56x | 1.51x | 1.66x | 1.51x | 2.29x |
| Goodwill | 2.33M | 0 | 0 | 0 | 14.32M | 41.98M | 0 | 0 | 37.71M | 52.48M |
| Intangible Assets | 0 | 0 | 1.5M | 1.77M | 2.73M | 14.26M | 10.62M | 8.09M | 34.83M | 46.7M |
| Long-Term Investments | 0 | 0 | 11.11M | 7M | 6.11M | 7.07M | 13.72M | 40.73M | 49.55M | 156.39M |
| Other Non-Current Assets | 467.49K | 714K | 592K | 8.03M | 31.11M | 32.36M | 19.09M | 591K | -45.96M | 12.84M |
| Total Assets | 92.81M▲ 0% | 302.57M▲ 226.0% | 428.52M▲ 41.6% | 417.62M▼ 2.5% | 554.02M▲ 32.7% | 577.11M▲ 4.2% | 298.45M▼ 48.3% | 407.86M▲ 36.7% | 562.21M▲ 37.8% | 530.24M▲ 0% |
| Asset Turnover | 0.06x | 0.04x | 0.19x | 0.21x | 0.14x | 0.25x | 0.50x | 0.39x | 0.33x | 0.51x |
| Asset Growth % | 72.29% | 226.01% | 41.63% | -2.54% | 32.66% | 4.17% | -48.28% | 36.66% | 37.84% | 169.78% |
| Total Current Liabilities | 6.65M | 11.25M | 43.86M | 29.08M | 26.27M | 55.28M | 22.43M | 53.32M | 126.16M | 93.97M |
| Accounts Payable | 6.26M | 10.76M | 40.35M | 17.49M | 18.95M | 40.86M | 14.73M | 47.1M | 64.08M | 71.02M |
| Days Payables Outstanding | 263.01 | -100.22 | 461.11 | 44.54 | 64.31 | 130.56 | 47.1 | 153.05 | 130.47 | 125.43 |
| Short-Term Debt | 389.82K | 421K | 3.51M | 11.6M | 80K | 80K | 76K | 60K | 25K | 946.23K |
| Deferred Revenue (Current) | 0 | 0 | -3.51M | 0 | 0 | 2.44M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -659 | 65K | 0 | 0 | 6.25M | 12M | 2.35M | 5.14M | 61.08M | 22.01M |
| Current Ratio | 6.72x | 18.06x | 4.47x | 5.85x | 9.92x | 4.01x | 6.95x | 4.92x | 1.62x | 1.62x |
| Quick Ratio | 5.91x | 12.30x | 1.88x | 3.39x | 8.06x | 2.77x | 3.34x | 3.37x | 0.64x | 0.64x |
| Cash Conversion Cycle | 32.35 | -480.05 | 891.95 | 209.64 | 198.16 | 203.68 | 278.96 | 199.97 | 249.12 | 162.44 |
| Total Non-Current Liabilities | 3.13M | 106.72M | 57.66M | 89.02M | 47.95M | 13.76M | 4.4M | 48.55M | 86.92M | 67.11M |
| Long-Term Debt | 3.13M | 98.74M | 46.07M | 103.67M | 230K | 155K | 3.63M | 25K | 7.76M | 7.5M |
| Capital Lease Obligations | 0 | 0 | 0 | 2.62M | 4.65M | 2.21M | 0 | 3.34M | 7.75M | 31.48M |
| Deferred Tax Liabilities | 0 | 7.98M | 10.47M | 0 | 0 | 3.62M | 0 | 0 | 0 | 17.65M |
| Other Non-Current Liabilities | 510 | 0 | 1.12M | -17.27M | 43.06M | 7.79M | 771K | 45.18M | 71.53M | 240.96M |
| Total Liabilities | 9.78M | 117.97M | 101.52M | 118.1M | 74.21M | 69.05M | 26.83M | 101.87M | 213.08M | 161.09M |
| Total Debt | 3.52M | 99.16M | 49.58M | 103.67M | 5.95M | 3.36M | 3.71M | 4.46M | 8.75M | 15.94M |
| Net Debt | 1.56M | 44.1M | 2.02M | 79.07M | -49.42M | -65.16M | -30.16M | -102.29M | -19.45M | -46.17M |
| Debt / Equity | 0.04x | 0.54x | 0.15x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x |
| Debt / EBITDA | - | 2.48x | 3.45x | - | - | - | - | - | - | -1.76x |
| Net Debt / EBITDA | - | 1.10x | 0.14x | - | - | - | - | - | - | 5.10x |
| Interest Coverage | -42.05x | 3.61x | 0.57x | -24.22x | -31.02x | -100.59x | -873.64x | - | - | - |
| Total Equity | 83.03M▲ 0% | 184.59M▲ 122.3% | 327.01M▲ 77.1% | 299.53M▼ 8.4% | 479.81M▲ 60.2% | 508.06M▲ 5.9% | 271.62M▼ 46.5% | 305.99M▲ 12.7% | 349.13M▲ 14.1% | 369.15M▲ 0% |
| Equity Growth % | 87.6% | 122.32% | 77.15% | -8.4% | 60.19% | 5.89% | -46.54% | 12.65% | 14.1% | 102.16% |
| Book Value per Share | 3.42 | 5.82 | 9.28 | 6.94 | 7.49 | 5.96 | 3.34 | 3.21 | 2.73 | 2.70 |
| Total Shareholders' Equity | 83.03M | 184.59M | 327.01M | 299.53M | 479.81M | 508.06M | 271.62M | 305.99M | 349.13M | 369.15M |
| Common Stock | 99.7M | 157.79M | 318.13M | 420.67M | 730.8M | 769.73M | 776.91M | 852.89M | 919.91M | 920.86M |
| Retained Earnings | -19.75M | 759K | -8.78M | -144.94M | -275.64M | -289.93M | -538.53M | -583.97M | -608.73M | -588.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 3.08M | 26.05M | 17.66M | 23.79M | 24.65M | 28.26M | 33.24M | 37.07M | 37.95M | 36.57M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OGI Cash Flow Statement
Organigram Global Inc. (OGI) cash flow — operating, investing & free cash flow history
| Line item | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -6.11M | -12.7M | -35.08M | -45.13M | -28.59M | -36.21M | -35.8M | 3.87M | -4.3M | -4.3M |
| Operating CF Margin % | -113.4% | -102.21% | -43.63% | -51.99% | -36.11% | -24.83% | -23.99% | 2.42% | -2.31% | - |
| Operating CF Growth % | -244.85% | -107.88% | -176.14% | -28.63% | 36.64% | -26.66% | 1.15% | 110.82% | -211.07% | 3.82% |
| Net Income | -10.89M | 22.12M | -9.5M | -136.16M | -130.7M | -14.28M | -229.48M | -45.44M | -24.76M | 18.15M |
| Depreciation & Amortization | 1.55M | 3.53M | 8.9M | 17.96M | 31.03M | 24.91M | 24.08M | 12.08M | 17.98M | 19.56M |
| Stock-Based Compensation | 2.21M | 5.03M | 14.89M | 7.8M | 3.9M | 5.13M | 5.29M | 7.18M | 4.22M | 2.89M |
| Deferred Taxes | -102.81K | -1.86M | 3.63M | -10.47M | 42.21M | -88K | 0 | 0 | -13.77M | -13.66M |
| Other Non-Cash Items | 625.14K | -643K | 4.01M | 46.71M | 776K | -29M | 151.8M | 15.09M | 14.16M | -25.12M |
| Working Capital Changes | 494.43K | -40.88M | -57.02M | 29.04M | 24.2M | -22.88M | 12.51M | 14.96M | -2.12M | -20.48M |
| Change in Receivables | -2.42M | 337K | -13.13M | 1.79M | -6.01M | -24.02M | 12.51M | -12.06M | -15.29M | -28.95M |
| Change in Inventory | 550.6K | -48.68M | -40.91M | 45.64M | 28.68M | -12.22M | 0 | 0 | 0 | 0 |
| Change in Payables | 3.89M | 3.98M | 10.56M | -28M | 2.06M | 12.15M | 0 | 0 | 0 | 0 |
| Cash from Investing | -42.6M | -98M | -46.78M | -138.2M | -115.11M | 44.03M | 4.56M | -38.77M | -59.35M | -24.25M |
| Capital Expenditures | -34.33M | -56.44M | -110.29M | -78.65M | -12.33M | -48.78M | -26.9M | -4.73M | -17.02M | -17.5M |
| CapEx % of Revenue | 637.04% | 454.06% | 137.16% | 90.62% | 15.57% | 33.45% | 18.03% | 2.96% | 9.15% | - |
| Acquisitions | 114.7K | 15K | -12.76M | -1.43M | -2.54M | -11.06M | 0 | 0 | -65.62M | -6.46M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 294.16K | -17K | 621K | -8.64M | -31.07M | 4.29M | 31.46M | -8.32M | 21.8M | -2.64M |
| Cash from Financing | 40.81M | 163.91M | 74.33M | 160.37M | 174.46M | 5.33M | -754.15K | 107.78M | 28.24M | 39.24M |
| Debt Issued (Net) | -1.78M | 114.77M | 46.18M | 63.34M | -116.4M | -1.01M | 0 | -786K | -43.08K | -1.11M |
| Equity Issued (Net) | 1000K | 1000K | 0 | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 8.93K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.33M | -8.36M | 28.15M | -2.97M | 5.99M | 6.34M | -754.15K | 6K | -1.29M | 40.35M |
| Net Change in Cash | -7.9M▲ 0% | 53.11M▲ 772.2% | -7.51M▼ 114.1% | -22.95M▼ 205.7% | 30.77M▲ 234.0% | 13.15M▼ 57.3% | -68.52M▼ 621.0% | 72.88M▲ 206.4% | -37.98M▼ 152.1% | -6.33M▲ 0% |
| Free Cash Flow | -40.44M▲ 0% | -69.14M▼ 71.0% | -145.38M▼ 110.3% | -123.78M▲ 14.9% | -40.92M▲ 66.9% | -84.99M▼ 107.7% | -62.7M▲ 26.2% | -1.47M▲ 97.7% | -16.52M▼ 1027.1% | -36.39M▲ 0% |
| FCF Margin % | -750.44% | -556.27% | -180.79% | -142.61% | -51.69% | -58.29% | -42.02% | -0.92% | -8.88% | -13% |
| FCF Growth % | -553.36% | -70.96% | -110.26% | 14.86% | 66.94% | -107.71% | 26.23% | 97.66% | -1027.05% | -195.52% |
| FCF per Share | -1.66 | -2.18 | -4.13 | -2.87 | -0.64 | -1.00 | -0.77 | -0.02 | -0.13 | -0.13 |
| FCF Conversion (FCF/Net Income) | 0.56x | -0.62x | 3.68x | 0.33x | 0.22x | 2.54x | 0.16x | -0.09x | 0.24x | -2.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OGI Key Ratios
Organigram Global Inc. (OGI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -17.11% | 15.33% | -3.73% | -43.46% | -33.54% | -2.89% | -58.86% | -15.73% | -5.43% | 4.92% |
| Return on Invested Capital (ROIC) | -13.16% | 17.44% | 1.48% | -30.84% | -17.03% | -7.41% | -53.2% | -12.02% | -17.83% | -17.83% |
| Gross Margin | -61.18% | -215.42% | 60.28% | -65.08% | -35.87% | 21.65% | 23.51% | 29.73% | 3.67% | 28.86% |
| Net Margin | -202.08% | 165.04% | -11.87% | -156.87% | -165.11% | -9.8% | -153.8% | -28.43% | -9.55% | 6.48% |
| Debt / Equity | 0.04x | 0.54x | 0.15x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x |
| Interest Coverage | -42.05x | 3.61x | 0.57x | -24.22x | -31.02x | -100.59x | -873.64x | - | - | - |
| FCF Conversion | 0.56x | -0.62x | 3.68x | 0.33x | 0.22x | 2.54x | 0.16x | -0.09x | 0.24x | -2.01x |
| Revenue Growth | -12.06% | 130.64% | 546.98% | 7.94% | -8.79% | 84.19% | 2.33% | 7.13% | 16.42% | 68.52% |
OGI Frequently Asked Questions
Organigram Global Inc. (OGI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Organigram Global Inc. (OGI) reported $279.9M in revenue for fiscal year 2025.
Organigram Global Inc. (OGI) grew revenue by 16.4% over the past year. This is strong growth.
Yes, Organigram Global Inc. (OGI) is profitable, generating $18.2M in net income for fiscal year 2025 (-9.6% net margin).
Dividend & Returns
Organigram Global Inc. (OGI) has a return on equity (ROE) of -5.4%. Negative ROE indicates the company is unprofitable.
Organigram Global Inc. (OGI) had negative free cash flow of $36.4M in fiscal year 2025, likely due to heavy capital investments.
Explore More OGI
Organigram Global Inc. (OGI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates